95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.68%
Revenue growth under 50% of AEM's 5.48%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
0.02%
Gross profit growth under 50% of AEM's 29.73%. Michael Burry would be concerned about a severe competitive disadvantage.
0.37%
EBIT growth below 50% of AEM's 41.75%. Michael Burry would suspect deeper competitive or cost structure issues.
0.37%
Operating income growth under 50% of AEM's 41.75%. Michael Burry would be concerned about deeper cost or sales issues.
-1.53%
Negative net income growth while AEM stands at 32.06%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Share reduction more than 1.5x AEM's 0.26%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.02%
Diluted share reduction more than 1.5x AEM's 0.11%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-29.69%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
3.56%
OCF growth at 50-75% of AEM's 5.50%. Martin Whitman would question if the firm lags in monetizing sales effectively.
3.57%
Positive FCF growth while AEM is negative. John Neff would see a strong competitive edge in net cash generation.
157.92%
10Y revenue/share CAGR at 75-90% of AEM's 200.19%. Bill Ackman would press for new markets or product lines to narrow the gap.
0.79%
Positive 5Y CAGR while AEM is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-0.77%
Negative 3Y CAGR while AEM stands at 12.95%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
139.61%
10Y OCF/share CAGR in line with AEM's 127.53%. Walter Schloss would see both as similarly efficient over the decade.
-19.65%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-13.05%
Negative 3Y OCF/share CAGR while AEM stands at 145.81%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
74.58%
Below 50% of AEM's 270.57%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-55.47%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
1100.37%
3Y net income/share CAGR above 1.5x AEM's 534.52%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
235.48%
10Y equity/share CAGR above 1.5x AEM's 52.11%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
36.34%
5Y equity/share CAGR above 1.5x AEM's 7.45%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
14.09%
3Y equity/share CAGR 1.25-1.5x AEM's 11.83%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
-17.06%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
65.81%
3Y dividend/share CAGR above 1.5x AEM's 8.95%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
56.16%
Our AR growth while AEM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-100.00%
Inventory is declining while AEM stands at 18.34%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.01%
Negative asset growth while AEM invests at 2.34%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.66%
50-75% of AEM's 1.16%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-10.39%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-4.14%
We cut SG&A while AEM invests at 0.84%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.